Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio's Mission to Transform Cardiac and Chronic Care Qardio, Inc. ("Qardio" or
bundle includes QardioArm is an award-winning, clinically-validated, portable blood pressure monitor to empower you to take control of your heart health. FSA/HSA eligible. QardioArm wireless blood pressure monitor measures your systolic, diastolic blood pressure, heart rate and has irregular heartbeat detection. It is FDA approved and is clinically validated to meet both US and European Standards. Its elegant and compact design means you can always have it by your side, using it anytime, anywhere. In fact, its unique function PLACES allows you to geo-track your readings across location as well as time. Qardio App is integrated with Apple Health and supports Apple Watch, and checking your health or the health of your loved ones is as easy as checking the time. QardioArm also works with S Health, on your Android devices, including Android Wear.
Bundle includes Arm Case for QardioArm Wireless Blood Pressure Monitor QardioArm wireless blood pressure monitor measures your systolic, diastolic blood pressure, heart rate and has irregular heartbeat detection. It is FDA approved and is clinically validated to meet both US and European Standards. Its elegant and compact design means you can always have it by your side, using it anytime, anywhere. In fact, its unique function PLACES allows you to geo-track your readings across location as well as time. Qardio App is integrated with Apple Health and supports Apple Watch, and checking your health or the health of your loved ones is as easy as checking the time. QardioArm also works with S Health, on your Android devices, including Android Wear.
Share this article SAN FRANCISCO, March 11, 2021 /PRNewswire/ Qardio, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510k clearance for its QardioCore ambulatory ECG device. QardioCore will initially be marketed for holter monitoring applications, for use with QardioMD, Qardio s cloud-based remote patient monitoring solution. QardioCore extends Qardio s remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform. The QardioCore ambulatory ECG from Qardio QardioCore extends Qardio s RPM platform from primary care and hypertension to acute care and cardiology QardioCore requires no special skin preparation, gels, adhesives, or patches. It can easily be self-fit, removed, and re-fit by the patient. Ideal for remote deployment, QardioCore does not require an in-clinic fitting. Qardio intends to launch the service in the U.S. in mid-2021.